Kevin T. Nead, M.D., MPhil
Department of Epidemiology, Division of Cancer Prevention and Population Sciences
Present Title & Affiliation
Primary Appointment
Member, Division of Cancer Prevention and Population Sciences, The University of Texas Graduate School of Biomedical Sciences, Houston, TX
Assistant Professor, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Member, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas
Assistant Professor, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2014 | Stanford University School of Medicine, Stanford, California, US, MD |
| 2012 | University of Cambridge, Cambridge, GB, MPhil (Masters) in Epidemiology |
| 2008 | University of Florida, Gainesville, Florida, US, BS in Zoology |
Postgraduate Training
| 2015-2019 | Clinical Residency, Radiation Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania |
| 2014-2015 | Clinical Internship, Internal Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania |
Board Certifications
| 2021 | American Board of Radiology (Radiation Oncology) |
Experience & Service
Other Appointments/Responsibilities
Associate Fellow, Leonard Davis Institute of Health Economics, Philadelphia, PA, 2015 - 2019
Institutional Committee Activities
Member, MedTech Innovation Council, 2024 - Present
Co-Director, Seminar Series Committee, Department of Epidemiology, 2024 - Present
Member, Institute for Data Science in Oncology (IDSO) Internal Advisory Council (IAC), 2024 - Present
Member, Occupational Cancer Prevention Symposium Planning Committee, 2024 - Present
Senator (Elected), Faculty Senate, 2023 - Present
Member (Elected), Physicians Referral Service Clinical Revenue Cycle Committee, 2023 - Present
Chair, Translational Research Committee, Department of Breast Radiation Oncology, 2022 - Present
Member, Department of Epidemiology Faculty Search Committee, 2022 - Present
Member, Department of Health Services Research Faculty Search Committee, 2022 - Present
Member, Division of Radiation Oncology Faculty Search Committee, 2021 - Present
Voting Member, Appropriate Use Criteria Breast Committee, 2021 - 2024
Director, Seminar Series Committee, Department of Epidemiology, 2020 - 2024
Member, Academic Review Committee for the Division of Education & Training, 2020 - 2023
Honors & Awards
| 2025 | Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Science, Nominated, The University of Texas MD Anderson Cancer Center |
| 2024 | JACC CardioOnc’s Young Author Achievement Award (Mentor), American College of Cardiology |
| 2024 | ASTRO Annual Meeting Travel Award, Biology, ASTRO |
| 2023 | Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center |
| 2022 | Educator of the Year, Association of Residents in Radiation Oncology (ARRO) |
| 2018 | Charles J. Epstein Trainee Award for Excellence in Human Genetics Research - Finalist, American Society of Human Genetics |
| 2018 | Conquer Cancer Foundation of ASCO Merit Award, The American Society of Clinical Oncology Foundation |
| 2016 | B. Leonard Holman Research Pathway, The American Board of Radiology |
| 2013 | Kaiser Permanente of Northern California Medical Student Scholarship, Kaiser Permanente |
| 2013 | MacKenzie Foundation Scholarship, MacKenzie Foundation |
| 2013 | Travel Grant, Society for Vascular Medicine |
| 2013 | Young Investigator Award - Finalist, American College of Cardiology |
| 2012 | 1st in Class - GlaxoSmithKline Award, University of Cambridge |
| 2012 | American Heart Association Student Scholarship in Cardiovascular Disease and Stroke, American Heart Association |
| 2012 | Distinction in the MPhil thesis, examinations, and degree, University of Cambridge |
| 2012 | Scholar-in-Training Award, American Association for Cancer Research |
| 2011 | Gates-Cambridge Scholarship, Gates-Cambridge |
| 2010 | Medical Scholars Research Fellowship, Stanford University |
| 2010 | Medical Student Research Fellowship, American Heart Association |
| 2008 | Academic-All American; First Team, Division I, National Collegiate Athletic Association (NCAA) |
| 2008 | Phi Beta Kappa, University of Florida |
| 2008 | Postgraduate Scholarship, National Collegiate Athletic Association (NCAA) |
| 2008 | Summa Cum Laude, University of Florida |
| 2008 | United States Olympic Swimming Trials Qualifier, United States Olympics |
| 2007 | Howard Hughes Medical Institute Undergraduate Research Fellowship, University of Florida |
| 2005 | United States Swimming National Championship Finalist, USA Swimming |
Selected Presentations & Talks
Local Presentations
- 2025. Screening/surveillance techniques. Invited. Occupational Flight Exposure and Cancer Risk Symposium, US.
- 2024. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Invited. Cancer Center Support Grant Cancer Prevention Program Meeting. Houston, Texas, US.
- 2024. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Invited. Research Town Hall. Houston, Texas, US.
- 2022. Hormone Therapy and Adverse Neurocognitive Outcomes. Invited. Division of Cancer Prevention and Population Sciences Grand Rounds, US.
- 2019. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Invited. Department of Radiation Oncology Seminar Series. Philadelphia, PA, US.
National Presentations
- 2024. Chicago-Wide Vascular Surgery Journal Club. Invited. Chicago, IL, US.
- 2024. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Conference. ASTRO 66th Annual Meeting. Washington, DC, US.
- 2024. Cancer, Aneurysms, & Atherosclerosis - Emerging Epidemiological Links. Invited. Vascular Scientific Sessions. Houston, TX, US.
- 2019. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Invited. Department of Epidemiology Seminar Series. Houston, TX, US.
- 2019. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Invited. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Houston, TX, US.
- 2018. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Invited. Etiology to outcomes: Integration of cancer genetics and the electronic health record. Nashville, TN, US.
- 2018. Risk of pediatric malignancy in families known to carry BRCA1/2 mutations. Poster. American Society of Clinical Oncology. Chicago, IL, US.
- 2018. Diagnostic radiation and testicular germ cell tumor risk. Poster. American Society for Clinical Oncology. San Francisco, CA, US.
- 2018. Association of clonal hematopoiesis mutations with adverse outcomes in a diverse hospital-based biobank. Conference. American Society of Human Genetics. San Diego, CA, US.
- 2017. Association of androgen deprivation therapy in the treatment of prostate cancer and depression: A systematic review and meta-analysis. Poster. American Society for Radiation Oncology. San Diego, CA, US.
- 2017. Influence of age on androgen deprivation therapy-associated Alzheimer's disease. Poster. American Association for Cancer Research. New Orleans, LA, US.
- 2017. Androgen deprivation therapy in the treatment of prostate cancer and dementia risk: A systematic review and meta-analysis. Poster. American Society of Clinical Oncology. Chicago, IL, US.
- 2016. Androgen deprivation therapy and risk of dementia. Conference. American Society for Radiation Oncology. Boston, MA, US.
- 2015. Text-mining methods applied to clinical records support an association between androgen deprivation therapy and subsequent cardiometabolic disease. Poster. American Association for Cancer Research. Philadelphia, PA, US.
- 2013. An alternative ankle-brachial index method identifies individuals at high-risk for cardiovascular mortality that are currently overlooked. Conference. American College of Cardiology. San Francisco, CA, US.
- 2012. Evidence of a causal association between fasting insulin concentrations and endometrial cancer: A Mendelian randomization analysis. Poster. American Association for Cancer Research. Anaheim, CA, US.
- 2012. The walking impairment questionnaire predicts total and cardiovascular mortality independent of peripheral artery disease status. Conference. American Heart Association. Los Angeles, CA, US.
Grant & Contract Support
| Date: | 2025 - 2028 |
| Title: | Clonal hematopoiesis and toxicity from radiation therapy |
| Funding Source: | CPRIT |
| Role: | PI |
| ID: | RP250062 |
| Date: | 2024 - 2025 |
| Title: | Characterization and Prediction of Second-Generation Anti-Androgen Associated Neurotoxicity in Patients with Prostate Cancer |
| Funding Source: | Cancer Neuroscience Program, MD Anderson |
| Role: | PI |
| Date: | 2021 - 2026 |
| Title: | Impact of clonal hematopoiesis mutations on toxicity and outcomes following oncologic therapy |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | K08CA263313 |
| Date: | 2021 - 2024 |
| Title: | Risk Factors and Mechanisms of Radiation-Induced Cardiovascular Disease |
| Funding Source: | Multidisciplinary Research Program (MRP) |
| Role: | Core Leader |
| ID: | RCTS#00059910 |
| Date: | 2020 - 2025 |
| Title: | Causes and consequences of clonal hematopoiesis mutations |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | L30CA253796 |
| Date: | 2020 - 2022 |
| Title: | Defining acquired mutations in healthy breast tissue and their association with breast cancer risk factors and breast cancer risk |
| Funding Source: | Duncan Family Institute |
| Role: | PI |
| Date: | 2020 - 2021 |
| Title: | Clonal hematopoiesis among individuals with non-hematologic cancer: association with comorbid disease and treatment toxicity |
| Funding Source: | Conquer Cancer Foundation of ASCO |
| Role: | PI |
| Date: | 2019 - 2022 |
| Title: | Science and Technology Acquisition and Retention Program (STARs) |
| Funding Source: | University of Texas (UT) |
| Role: | PI |
| Date: | 2019 - 2025 |
| Title: | Recruitment of First-Time, Tenure-Track Faculty Members |
| Funding Source: | CPRIT |
| Role: | PI |
| ID: | RR190077 |
| Date: | 2019 - 2019 |
| Title: | Clonal hematopoiesis among individuals with non-hematologic cancer: association with comorbid disease and treatment toxicity |
| Funding Source: | Marlene Shlomchik Fellowship in Cancer Research; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine |
| Role: | PI |
| Date: | 2018 - 2019 |
| Title: | Risk of cancer in children among families known to carry BRCA1/2 mutations |
| Funding Source: | The Gerber Foundation |
| Role: | PI |
Patient Reviews
CV information above last modified March 24, 2025